Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Randomised, Placebo Controlled, Parallel Group Study of Sativex When Added to the Existing Treatment Regimen, in the Relief of Central Neuropathic Pain in Subjects With Multiple Sclerosis

NCT00391079 is registered in ClinicalTrials.gov with GW Pharmaceuticals Ltd as lead sponsor.

NCT NCT00391079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Randomised, Placebo Controlled, Parallel Group Study of Sativex When Added to the Existing Treatment Regimen, in the Relief of Central Neuropathic Pain in Subjects With Multiple Sclerosis
Lead sponsor
GW Pharmaceuticals Ltd
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2008
Enrollment
339 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis